Fitch: New Treasury Rules Sink Pfizer-Allergan Deal

NEW YORK--(BUSINESS WIRE)-- Proposed US Treasury Dept. rules that scuttled the Pfizer-Allergan merger could have broad implications for multinational corporations, including the spate of healthcare companies that re-domiciled in tax-advantaged overseas jurisdictions through inversions during the last several years, Fitch Ratings says.

Treasury and the IRS Tuesday announced plans intended to target "serial inverters" - companies that seemingly reduce taxes by relocating headquarters overseas. Pfizer's subsequent cancellation of its planned merger with Allergan makes this transaction the first high-profile victim of these rules.

The rules propose limiting the amount of money foreign parent companies can lend to US subsidiaries, and also temporarily limit the contribution of recent acquisitions of American companies to the foreign ownership hurdle needed for a transaction to meet the requirements for an inversion. It is this second provision that seems to have sunk the Pfizer-Allergan merger.

Although the Pfizer-Allergan combination offered some interesting strategic benefits, the cancellation of the merger indicates that tax synergies were the overwhelming factor supporting the transaction. In general, Fitch views the tax advantages resulting from a move overseas as beneficial to a company's liquidity and credit profile. The proposed rules erode this benefit by limiting a practice commonly known as "earnings-stripping," which refers to ways for a company with an international domicile to reduce its U.S. taxable profits.

To the extent the proposed rules make it more onerous for multi-national companies to reduce US taxable profits, this rule could lead companies to increase debt to fund shareholder payments. This would somewhat erode liquidity profile benefits that healthcare companies gained through recent overseas relocations. The new rules seem to target use of earnings stripping for shareholder payouts since they do not apply the same prohibitions on earnings stripping for business investment in the US.

Additional information is available on www.fitchratings.com.

The above article originally appeared as a post on the Fitch Wire credit market commentary page. The original article, which may include hyperlinks to companies and current ratings, can be accessed at www.fitchratings.com. All opinions expressed are those of Fitch Ratings.

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160407006203/en/

Fitch Ratings
Megan Neuburger, CFA
Managing Director
+1 212-908-0501
Fitch Ratings, Inc.
33 Whitehall Street
New York, NY 10004
or
Kellie Geressy-Nilsen
Senior Director
Fitch Wire
+1 212 908-9123
or
Media Relations:
Alyssa Castelli, +1-212-908-0540
[email protected]

Source: Fitch Ratings

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Carlyle sees improving exit conditions for "good companies"
• Sterling Construction (STRL) PT Lowered to $742 at Cantor Fitzgerald
• Truist on TTM Technologies (TTMI): 'Following big selloff, Buy into Q2 earnings'